Lesson learned. I really should have put a time li
Post# of 30028
Posted On: 08/16/2016 9:57:22 PM
Lesson learned. I really should have put a time limit on the last couple of posts, but nice to see the word of mouth and the interest, along with no hang ups on typos.
I did send out the EU MANF grant and research update over 30+ investors. It was nice to see many investors that support the company but don't want to get into the negativity whirlpool on the boards.
Sorry I didn't have more time to track down the grants from all the companies and institutions I shared, but for the ones you can see, there is more money flowing into MANF research in the EU that you'll never hear about. It would probably take 2-3 hours to track down the rest. I'd may need a grant to to track the grants.
Why doesn't the company post every grant that's awarded?
My assumption, right or wrong, is the company holds the license, but the research is being done all over the world at no cost to the company. I think they said as much previously. They are not going to PR every time an institution gets a grant. Keep in mind, each peer reviewed research document you see usually has funding behind it leading up to it and I shared quite a few.
"Are you kidding me? Institutions don't just do this research to keep PHD's busy with the tuition dollars?" No, that's not how it works.
I'll send out the US MANF research this week which includes the very large grant awarded this year. Not sure I have the time and energy to dig into Asia, but there is more going on there as well but the translations are exhausting. As Maggie posted, the company has been invited to the China. What the heck for? Won't be long for the bashers to suggest it's for the free egg rolls.
One of the quiet investors that reached out can relate to this based on their handle.
"You take the blue pill, the story ends. You wake up in your bed and believe whatever you want to believe. You take the red pill..."
Best of luck to you and everyone else.
I did send out the EU MANF grant and research update over 30+ investors. It was nice to see many investors that support the company but don't want to get into the negativity whirlpool on the boards.
Sorry I didn't have more time to track down the grants from all the companies and institutions I shared, but for the ones you can see, there is more money flowing into MANF research in the EU that you'll never hear about. It would probably take 2-3 hours to track down the rest. I'd may need a grant to to track the grants.
Why doesn't the company post every grant that's awarded?
My assumption, right or wrong, is the company holds the license, but the research is being done all over the world at no cost to the company. I think they said as much previously. They are not going to PR every time an institution gets a grant. Keep in mind, each peer reviewed research document you see usually has funding behind it leading up to it and I shared quite a few.
"Are you kidding me? Institutions don't just do this research to keep PHD's busy with the tuition dollars?" No, that's not how it works.
I'll send out the US MANF research this week which includes the very large grant awarded this year. Not sure I have the time and energy to dig into Asia, but there is more going on there as well but the translations are exhausting. As Maggie posted, the company has been invited to the China. What the heck for? Won't be long for the bashers to suggest it's for the free egg rolls.
One of the quiet investors that reached out can relate to this based on their handle.
"You take the blue pill, the story ends. You wake up in your bed and believe whatever you want to believe. You take the red pill..."
Best of luck to you and everyone else.
(15)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼